Cargando…

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer

Drug resistance is a key factor in the treatment failure of clinical non-small cell lung cancer (NSCLC) patients after adjuvant chemotherapy. Here, our results provide the first evidence that eukaryotic translation initiation factor 2b subunit delta (EIF2B4)-Stratifin (SFN) fusion and increased SFN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yu-Shui, Hou, Li-Kun, Yao, Shi-Hua, Liu, Ji-Bin, Yu, Xue-Chen, Shi, Yi, Yang, Xiao-Li, Wu, Wei, Wu, Chun-Yan, Jiang, Geng-Xi, Fu, Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426184/ https://www.ncbi.nlm.nih.gov/pubmed/34553022 http://dx.doi.org/10.1016/j.omto.2021.07.005

Ejemplares similares

Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma
por: Robin, Fabien, et al.
Publicado: (2020)

Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway
por: Ye, Shan-Ping, et al.
Publicado: (2023)

Serum Extracellular Vesicle Stratifin Is a Biomarker of Perineural Invasion in Patients With Colorectal Cancer and Predicts Worse Prognosis
por: Hou, Wenyun, et al.
Publicado: (2022)

Stratifin accelerates progression of lung adenocarcinoma at an early stage
por: Shiba-Ishii, Aya, et al.
Publicado: (2015)

Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage
por: Arakawa, Noriaki, et al.
Publicado: (2022)

High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma
por: Xu, He, et al.
Publicado: (2018)

CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation
por: Sun, Bryan K., et al.
Publicado: (2015)

Stratifin (14-3-3 σ) Limits Plakophilin-3 Exchange with the Desmosomal Plaque
por: Roberts, Brett J., et al.
Publicado: (2013)

Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression
por: Arakawa, Noriaki, et al.
Publicado: (2022)

A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer
por: Mogal, Md Roman, et al.
Publicado: (2022)

Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma
por: Xie, XueCheng, et al.
Publicado: (2017)

Crystal structure of human profilaggrin S100 domain and identification of target proteins annexin II, stratifin and hsp27
por: Bunick, Christopher G, et al.
Publicado: (2015)

High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy
por: Yang, Guang, et al.
Publicado: (2015)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Stratifin (SFN) regulates lung cancer progression via nucleating the Vps34‐BECN1‐TRAF6 complex for autophagy induction
por: Kim, Ji Young, et al.
Publicado: (2022)

Elevated mean platelet volume predicts poor prognosis in colorectal cancer
por: Li, Na, et al.
Publicado: (2017)

Poor prognosis of heart failure patients with in‐hospital worsening renal function and elevated BNP at discharge
por: Okabe, Toshitaka, et al.
Publicado: (2020)

Poly(ADP-ribose) polymerase-3 overexpression is associated with poor prognosis in patients with breast cancer following chemotherapy
por: Song, Zhiguo, et al.
Publicado: (2018)

CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients
por: Tan, Li-Ming, et al.
Publicado: (2019)

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
por: Dai, Da-nian, et al.
Publicado: (2017)

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
por: Keck, Bastian, et al.
Publicado: (2013)

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2015)

Elevated SPINK2 gene expression is a predictor of poor prognosis in acute myeloid leukemia
por: Xue, Cuiling, et al.
Publicado: (2019)

High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

Elevated Platelet Distribution Width Predicts Poor Prognosis in Gallbladder Carcinoma
por: Liu, Fei, et al.
Publicado: (2021)

Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer
por: Ye, Rui, et al.
Publicado: (2017)

TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
por: Xue, Jiapeng, et al.
Publicado: (2023)

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer
por: Zang, Jialan, et al.
Publicado: (2017)

Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
por: Ye, Jia-Hui, et al.
Publicado: (2020)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
por: Zhang, Peng-Fei, et al.
Publicado: (2019)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

p-Coumaric Acid Attenuates UVB-Induced Release of Stratifin from Keratinocytes and Indirectly Regulates Matrix Metalloproteinase 1 Release from Fibroblasts
por: Seok, Jin Kyung, et al.
Publicado: (2015)

Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma
por: Fan, Weibing, et al.
Publicado: (2017)

Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis
por: Cheng, Kai-Chung, et al.
Publicado: (2019)

Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients
por: Wan, Guoxing, et al.
Publicado: (2016)

Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer
por: Ding, Mina, et al.
Publicado: (2018)

Elevated Serum Complement C1q Levels After Traumatic Brain Injury and Its Association with Poor Prognosis
por: Yan, Xin-Jiang, et al.
Publicado: (2022)

Failure of Elevating Calcium Induces Oxidative Stress Tolerance and Imparts Cisplatin Resistance in Ovarian Cancer Cells
por: Ma, Liwei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_soc6tk46g5d6896d9ie1tr0utd